조현병 환자를 위한 정신사회적 중재 = Psychosocial Intervention for Patients with Schizophrenia

다국어 초록 (Multilingual Abstract)

Treatment of schizophrenia has as its ultimate goals, the functional recovery of the patients and improvement of their quality of life. While antipsychotic medication is the fundamental method for treating schizophrenia, it has certain limitations in terms of treating the illness beyond its positive symptoms. Therefore, psychosocial intervention should be used in tandem with pharmacological methods in treating schizophrenia. The efficacy of several modes of psychosocial intervention for improving outcomes in schizophrenia is well attested. Approximately 10 modes of psychosocial intervention have been recommended based on existing evidence, including family intervention, cognitive behavioral therapy, supported employment, early intervention services, lifestyle intervention for physical health enhancement, treatment of comorbid substance abuse, assertive community treatment, cognitive remediation, social skills training, and peer support. Ideally, these interventions are offered to patients in combination with one another. Over the last decade, increased emphasis has been placed on early detection and intervention, with particular focus on long-term recovery. Early intervention with comprehensive psychosocial interventions should be enacted promptly from the initial detection of schizophrenia.

목차 (Table of Contents)

• 서론
• 근거 기반 정신사회적 중재
• 지역사회 정신보건 서비스
• 결론

참고문헌 (Reference)

1 이가영, "젊은 조현병 환자의 사회복귀를 위한 인지행동치료 기반 집중사례관리 증례" 대한조현병학회 19 (19): 32-37, 2016

2 Hjorthøj C, "Years of potential life lost and life expectancy in schizophrenia : a systematic review and meta-analysis" 4 : 295-301, 2017

3 Sung-Wan Kim, "Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population" 대한신경정신의학회 15 (15): 111-117, 2018

4 Na E, "Treatment of tobacco use disorders in people with mental illness" 6 : 78-85, 2015

5 Baandrup L, "Treatment of adult patients with schizophrenia and complex mental health needs-a national clinical guideline" 70 : 231-240, 2016

6 McGorry PD, "The recognition and optimal management of early psychosis : an evidence-based reform" 1 : 76-83, 2002

7 Edwards J, "The recognition and management of early psychosis. A preventive approach" Cambridge University Press 1999

8 Caton CL, "The need for close monitoring of early psychosis and cooccurring substance misuse" 35 : 241-243, 2011

9 Nestor P, "The employment of consumers in mental health services : politically correct tokenism or genuinely useful?" 16 : 344-347, 2008

10 Mueser KT, "The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components" 66 : 680-690, 2015

11 Dixon LB, "The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements" 36 : 48-70, 2010

12 Kinoshita Y, "Supported employment for adults with severe mental illness" 9 : CD008297-, 2013

13 Mizrahi R, "Social stress and psychosis risk : common neurochemical substrates?" 41 : 666-674, 2016

14 Galletly C, "Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders" 50 : 410-472, 2016

15 Álvarez-Jiménez M, "Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years" 42 : 595-606, 2012

16 Kim SW, "Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 Ssudy" 11 : e0151417-, 2016

17 Perkins DO, "Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia : a critical review and meta-analysis" 162 : 1785-1804, 2005

18 Morin L, "Rehabilitation interventions to promote recovery from schizophrenia : a systematic review" 8 : 100-, 2017

19 Birchwood M, "Reducing duration of untreated psychosis : care pathways to early intervention in psychosis services" 203 : 58-64, 2013

20 National Collaborating Centre for Mental Health, "Psychosis and schizophrenia in adults: the NICE guideline on treatment and management"

21 Mathers CD, "Projections of global mortality and burden of disease from 2002 to 2030" 3 : e442-, 2006

22 Brabban A, "Predictors of outcome in brief cognitive behavior therapy for schizophrenia" 35 : 859-864, 2009

23 Marder SR, "Physical health monitoring of patients with schizophrenia" 161 : 1334-1349, 2004

24 Kendall T, "NICE v. SIGN on psychosis and schizophrenia: same roots, similar guidelines, different interpretations" 208 : 316-319, 2016

25 Louise S, "Mindfulness-and acceptance-based interventions for psychosis : our current understanding and a meta-analysis" 192 : 57-63, 2018

26 Khoury B, "Mindfulness interventions for psychosis : a meta-analysis" 150 : 176-184, 2013

27 van Oosterhout B, "Metacognitive training for schizophrenia spectrum patients : a meta-analysis on outcome studies" 46 : 47-57, 2016

28 Scottish Intercollegiate Guidelines Network, "Management of schizophrenia (SIGN Guideline No. 131)"

29 Kim EJ, "Low dietary intake of n-3 fatty acids, niacin, folate, and vitamin C in Korean patients with schizophrenia and the development of dietary guidelines for schizophrenia" 45 : 10-18, 2017

30 Amminger GP, "Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study" 6 : 7934-, 2015

31 Grácio J, "Key elements of a family intervention for schizophrenia : a qualitative analysis of an RCT" 57 : 100-112, 2018

32 Brewer WJ, "Intensive case management for high-risk patients with first-episode psychosis : service model and outcomes" 2 : 29-37, 2015

33 Marder SR, "Integrating pharmacological and psychosocial treatments for schizophrenia" 407 : 87-90, 2000

34 Jukić V, "Importance of the newer generations of antipsychotics in reducing schizophrenia hospitalization rates" 25 : 329-333, 2013

35 National Institute for Clinical Excellence, "Implementing the early intervention in psychosis access and waiting time standard: Guidance" NHS England Publications 2016

36 Rickwood DJ, "Headspace-Australia’s innovation in youth mental health : who are the clients and why are they presenting?" 200 : 108-111, 2014

37 Chung YC, "Group cognitivebehavioral therapy for early psychosis" 37 : 403-411, 2013

38 Marom S, "Expressed emotion : relevance to rehospitalization in schizophrenia over 7 years" 31 : 751-758, 2005

39 McFarlane WR, "Employment outcomes in family-aided assertive community treatment" 70 : 203-214, 2000

40 Varga E, "Efficacy of metacognitive training compared with a psychosocial rehabilitation program on social cognitive processing in schizophrenia" 27 : S959-, 2017

41 Rimes RR, "Effects of exercise on physical and mental health, and cognitive and brain functions in schizophrenia: clinical and experimental evidence" 14 : 1244-1254, 2015

42 김성완, "Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis" 대한신경정신의학회 14 (14): 609-617, 2017

43 Iyer S, "Early intervention for psychosis : a Canadian perspective" 203 : 356-364, 2015

44 Bond GR, "Does competitive employment improve nonvocational outcomes for people with severe mental illness?" 69 : 489-501, 2001

45 Beauchamp MC, "Do personality traits matter when choosing a group therapy for early psychosis?" 86 : 19-32, 2013

46 Kim SW, "Development and feasibility of smartphone application for cognitive behavioural case management of individuals with early psychosis" 2017

47 Zhang Z, "Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study" 14 : 212-, 2014

48 Pitt V, "Consumer-providers of care for adult clients of statutory mental health services" 3 : CD004807-, 2013

49 Kane JM, "Comprehensive versus usual community care for first-episode psychosis : 2-year outcomes from the NIMH RAISE early treatment program" 173 : 362-372, 2016

50 Correll CU, "Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and metaregression" 75 : 555-565, 2018

51 Barnes TR, "Comorbid substance use and age at onset of schizophrenia" 188 : 237-242, 2006

52 Nelson B, "Cognitive Behavioural Case Management (CBCM) for the NEURAPRO-E study. version 1" Orygen Youth Health 2008

53 Kim KR, "Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis" 5 : 174-178, 2011

54 Norman R, "Canadian treatment guidelines on psychosocial treatment of schizophrenia in adults" 62 : 617-623, 2017

55 Addington J, "Canadian treatment guidelines for individuals at clinical high risk of psychosis" 62 : 656-661, 2017

56 Crockford D, "Canadian schizophrenia guidelines : schizophrenia and other psychotic disorders with coexisting substance use disorders" 62 : 624-634, 2017

57 Addington D, "Canadian practice guidelines for comprehensive community treatment for schizophrenia and schizophrenia spectrum disorders" 62 : 662-672, 2017

58 Roffman JL, "Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial" 23 : 316-322, 2018

59 Marshall M, "Assertive community treatment for people with severe mental disorders" 4 : CD001089-, 2011

60 Craig TK, "AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial" 5 : 31-40, 2018